# A Multicenter Randomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus DXM Versus DXM in Treatment of ITP

> **NCT05023915** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Shandong University** · enrollment: 106 (estimated)

## Conditions studied

- Immune Thrombocytopenia

## Interventions

- **DRUG:** dexamethasone
- **DRUG:** diammonium glycyrrhizinate enteric-coated capsule

## Key facts

- **NCT ID:** NCT05023915
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-08-21
- **Primary completion:** 2021-08-21
- **Final completion:** 2026-01-31
- **Target enrollment:** 106 (ESTIMATED)
- **Last updated:** 2026-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05023915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05023915, "A Multicenter Randomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus DXM Versus DXM in Treatment of ITP". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05023915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*